Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.2460
-0.0081-3.19%
IGC Pharma Inc (IGC) Stock Price, Quote, News & History
IGCAMEX
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of IGC Pharma (AMEX:IGC) through any online brokerage.
Other companies in IGC Pharma’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
IGC Pharma has a consensus price target of $4.75.
The stock price for IGC Pharma (AMEX: IGC) is $ last updated .
There are no upcoming dividends for IGC Pharma.
IGC Pharma does not have any upcoming earnings scheduled.
There is no upcoming split for IGC Pharma.
IGC Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the AMEX.
